Skip to main content
. 2021 Jul 30;10(15):3377. doi: 10.3390/jcm10153377

Table 3.

The effects of antidepressant drugs on BDNF and IGF-1.

Group of Antideoressants Medication Study Duration of the Study (Weeks) Patient Group (n) Effect *
BDNF
SSRI Sertraline Wolkowitz et al. [21] 8 n = 10
Brunoni et al. [19] 6 n = 18
Umene-Nakano et al. [58] 8 n = 59 ↑ (responders only)
Matrisciano et al. [54] 6 months n = 7
Gonul et al. [59] 8 n = 8
Escitalopram Wolkowitz et al. [21] 8 n = 15
Matrisciano et al. [54] 6 months n = 7
Aydemir et al. [60] 6 n = 20
Chiou et al. [39] 4 n = 2
Paroxetine Yoshimura et al. [61] 8 n = 21
Gonul et al. [59] 8 n = 3
Chiou et al. [39] 4 n = 7
Hellweg et al. [56] 36 days n = 20
Fluoxetine Başterzi et al. [55] 6 n = 22 ↑/↓
Gupta et al. [40] 12 n = 30
Gonul et al. [59] 8 n = 5
Ghosh et al. [62] 12 n = 30
Chiou et al. [39] 44 n = 21
SNRI Vortixetine Troyan et al. [41] 8 n = 30
Sagud et al. [42] 4 n = 44
Venlafaxine Başterzi et al. [55] 6 n = 21
Matrisciano et al. [54] 6 months n = 7 ↑ (after 6 months of treatment)
Katsuki et al. [63] 4 n = 48
Gonul et al. [59] 8 n = 10
Chiou et al. [39] 4 n = 8
Deuschle et al. (2012) [64] 28 days n = 27
Duloxetine Mikoteit et al. [65] 6 n = 21
Other Mirtazapine Fornaro et al. [66] 12 n = 30 ↑ early non-responders,
↔ early responders
Deuschle et al. (2012) [64] 28 days n = 29
Chiou et al. [39] 4 n = 3
Ketamine Zheng et al. [43] 26 days n = 94
Milnacipran Yoshimura et al. [61] 8 n = 21
Amitryptyline Hellweg et al. [56] 36 days n = 20
IGF-1
SSRI N/A Kopczak et al. [46] 6 n = 13
Fluoxetine Citalopram Paroxetine
Sertraline
Fluvoxamine
Bot et al. [44] N/A n = 52
n= 96
n = 195
n = 40
n = 38




SNRI N/A Kopczak et al. [46] 6 n = 12
Vortioxetine Troyan et al. [41] 8 n = 41
Levada et al. [45] 8 n = 48
Venlafaxine Bot et al. [44] N/A n = 95
TCA Clomipramine
Amitriptyline
Bot et al. [44] N/A n = 26
n = 21


(not statistically significant)
N/A Kopczak et al. [46] 6 n = 14
Other Mirtazapine Kopczak et al. [46] 6 n = 8
Bot et al. [44] N/A n = 33 ↓ (not statistically significant)

* ↑ increase, ↓ decrease, unchanged.